Back
ESC Professional Premium Access

Non-vitamin K antagonist oral anticoagulants (NOACs) attenuate valvular calcification in patients with severe aortic stenosis

Session: Pathomechanisms and treatment of valve disease
Topic: Valvular Heart Disease
Speaker: Ms M. Kopytek (Krakow, PL)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Ms Magdalena Kopytek

John Paul II Hospital, Krakow (Poland)
0 follower

5 more presentations in this session

Loss of ceramide synthase 5 reduces the development of aortic valve stenosis in mice with high fat diet.

Speaker: Ms L. Reese (Bonn, DE)

Access
Abstract
Slides
Like
Thumbnail

Unravelling the role of SOCS3 in aortic valve stenosis

Speaker: Doctor H. Billig (Bonn, DE)

Access
Abstract
Slides
Like
Thumbnail

Specific gene domains most commonly affected by CHIP-driver mutations predicting mortality in severe aortic stenosis after transcatheter aortic valve implantation

Speaker: Associate Professor S. Mas-Peiro (Frankfurt, DE)

Access
Abstract
Slides
Like
Thumbnail

Histology-verified myocardial fibrosis and quantification in severe AS patients: correlation with non-invasive LV myocardial tissue assessment

Speaker: Doctor S. Maltes (Lisbon, PT)

Access
Abstract
Slides
Like
Thumbnail

Autologous or bovine pericardium for aortic cusp replacement? Histomorphological and biomechanical properties as decision making tools

Speaker: Doctor C. Dittfeld (Dresden, DE)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Pathomechanisms and treatment of valve disease

Speakers: Ms M. Kopytek, Ms L. Reese, Doctor H. Billig, Associate Professor S. Mas-Peiro, Doctor S. Maltes...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources